Advanced Search

Technical Analysis for SQZ - SQZ Biotechnologies Company

Grade Last Price % Change Price Change
C 13.52 4.97% 0.64
SQZ closed up 4.97 percent on Wednesday, June 23, 2021, on 1.48 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Flat
Historical SQZ trend table...
Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 50 DMA Bearish 4.97%
Bollinger Band Squeeze Range Contraction 4.97%
BB Squeeze + Lower Band Touch Range Contraction 4.97%
Below Lower BB Weakness 4.97%
Down 3 Days in a Row Weakness 4.97%
Older End-of-Day Signals for SQZ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR about 14 hours ago
20 DMA Resistance about 15 hours ago
Rose Above 20 DMA about 16 hours ago
Rose Above 10 DMA about 16 hours ago
Up 5% about 16 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ Cell Therapy Platform, which uses membrane disruption to deliver material into cells. The company was founded in March 2013 and is headquartered in Watertown, MA.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Biology Infectious Diseases Molecular Biology Cell Biology Cell Therapy Therapies For Patients With Cancer

Is SQZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jun 23 SQZ presents data on use of its technology platform for stem cells
Jun 23 SQZ Biotechnologies Presents Regenerative Medicine Data Demonstrating Neuron Generation from Human Pluripotent Stem Cells with Single Delivery of mRNA Transcription Factor
Jun 9 Preclinical data shows SQZ cell line platform may treat autoimmune diseases
Jun 9 The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Jun 9 SQZ Biotechnologies' TAC Program Induces Multiple Mechanisms Of Antigen-Specific Tolerance, Animal Study Shows
Jun 9 SQZ Biotechnologies Tolerizing Antigen Carrier (TAC) Program Induces Antigen-Specific Immune Tolerance in Preclinical Models Demonstrating Potential for Broad Applicability Across Autoimmune Diseases
Jun 4 SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors
May 27 SQZ Biotech to Present at Jefferies Virtual Health Care Conference
May 19 SQZ Biotechnologies to Present First Clinical Data at the American Society of Clinical Oncology Annual Meeting from Ongoing Phase 1 Study in Patients with Advanced or Metastatic HPV+ Tumors
May 16 Brokers Are Upgrading Their Views On SQZ Biotechnologies Company (NYSE:SQZ) With These New Forecasts
See more SQZ news...

Indicators

Indicator Value
52 Week High 36.49
52 Week Low 11.15
Average Volume 179,942
200-Day Moving Average 0.00
50-Day Moving Average 12.90
20-Day Moving Average 13.53
10-Day Moving Average 13.47
Average True Range 0.75
ADX 22.89
+DI 16.68
-DI 15.12
Chandelier Exit (Long, 3 ATRs) 12.26
Chandelier Exit (Short, 3 ATRs) 14.86
Upper Bollinger Bands 13.98
Lower Bollinger Band 13.07
Percent B (%b) 0.49
BandWidth 6.72
MACD Line 0.09
MACD Signal Line 0.14
MACD Histogram -0.0535
Fundamentals Value
Market Cap 324.1 Million
Num Shares 24 Million
EPS -1.61
Price-to-Earnings (P/E) Ratio -8.37
Price-to-Sales 15.16
Price-to-Book 7.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.57
Resistance 3 (R3) 14.50 14.07 14.40
Resistance 2 (R2) 14.07 13.81 14.11 14.34
Resistance 1 (R1) 13.80 13.64 13.94 13.87 14.28
Pivot Point 13.37 13.37 13.44 13.41 13.37
Support 1 (S1) 13.10 13.11 13.24 13.17 12.76
Support 2 (S2) 12.67 12.94 12.71 12.70
Support 3 (S3) 12.40 12.67 12.65
Support 4 (S4) 12.47